Denali Therapeutics Inc (DNLI) — Financial Flexibility Index
Denali Therapeutics Inc (DNLI) has a Financial Flexibility Index of -0.38x as of March 2026. Free cash flow of $-128.74 Million (operating CF $-131.20 Million minus capex $2.47 Million) represents 0% of total liabilities ($339.93 Million). Check Denali Therapeutics Inc (DNLI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Denali Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Denali Therapeutics Inc across 11 annual periods. See DNLI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Denali Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Denali Therapeutics Inc. For the full company profile including market capitalisation, see DNLI market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.07x | $-403.10 Million | $-412.60 Million | $131.09 Million | ▼ -33.9% |
| 2024 | -2.30x | $-331.78 Million | $-347.69 Million | $144.50 Million | ▲ +18.2% |
| 2023 | -2.81x | $-345.05 Million | $-357.99 Million | $122.96 Million | ▼ -416.8% |
| 2022 | -0.54x | $-226.88 Million | $-244.72 Million | $417.81 Million | ▼ -18.3% |
| 2021 | -0.46x | $-202.89 Million | $-211.39 Million | $441.87 Million | ▼ -149.7% |
| 2020 | 0.92x | $419.25 Million | $416.15 Million | $453.75 Million | ▲ +209.5% |
| 2019 | -0.84x | $-133.66 Million | $-151.58 Million | $158.34 Million | ▼ -281.6% |
| 2018 | 0.46x | $53.51 Million | $50.12 Million | $115.14 Million | ▲ +113.2% |
| 2017 | -3.52x | $-73.76 Million | $-76.64 Million | $20.93 Million | ▲ +11.9% |
| 2016 | -4.00x | $-66.22 Million | $-72.36 Million | $16.55 Million | ▼ -1646.2% |
| 2015 | -0.23x | $-11.99 Million | $-15.05 Million | $52.32 Million | — |